The Food and Drug Administration is warning people to be on the lookout for counterfeit Ozempic, the diabetes drug that many people use off-label for weight loss. The federal agency and Novo ...

What is it? A medication called semaglutide, which is sold under different brand names, including Ozempic, approved in 2017 for treating type 2 diabetes, and Wegovy, approved just last year for ...

The complexity of Ozempic use for weight loss extends beyond individual health decisions to broader public health implications. This situation calls for continued dialogue between healthcare ...

Who gets Ozempic? People with private insurance and generous health plans, study shows Though Martin says her telehealth experience has been positive, she understands it's a controversial route to ...

JD Vance faced backlash for his controversial remarks about Ozempic, a diabetes and weight loss drug. During a podcast ...

A National Geographic investigation explores the controversial lab-for-hire industry ... than half of the animals sourced from Cambodia. Ozempic and Wegovy, medications that have become ...

after its meteoric yet controversial rise in 2023 and 2024, is the Ozempic phenomenon. A prescription drug, Ozempic has been making its presence felt among Holly and Bolly stars, in fashion and ...

Golden Globes host Nikki Glaser caused some controversy with her March 24 appearance on The Tonight Show after she proudly advocated for Ozempic and plastic surgery. And she further stoked the ...

In the summer of 2022, I decided to try taking Ozempic to lose weight. At the time, I was an early adopter. The media frenzy about GLP-1 agonists hadn't yet started. Even my own doctor was ...

Despite her firm denials of ever using Ozempic, the rumors persist ... with many attributing her new look to the controversial drug. The public's fascination with her transformation highlights ...

This isn't the first public warning about counterfeit Ozempic. In 2023, the FDA alerted the public to thousands of counterfeit doses that had gotten into circulation. A spokesperson for Novo ...